IDEXX Laboratories (IDXX) Revenue — Quarter Ended Dec 31, 2025
Revenue for the quarter declined from the prior quarter, marking a reversal from the sequential growth seen in the first three quarters. However, compared to the same quarter a year ago, revenue increased, reflecting sustained year-over-year momentum.
Key takeaway
Quarter ended Dec 31, 2025 · FY2025 Q4
Revenue for the quarter declined from the prior quarter, marking a reversal from the sequential growth seen in the first three quarters. However, compared to the same quarter a year ago, revenue increased, reflecting sustained year-over-year momentum.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
-1.3%
Change from the immediately preceding quarter.
Year-over-year
+14.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $998.4M | +3.6% |
| Jun 30, 2025 | $1.1B | +10.6% |
| Sep 30, 2025 | $1.1B | +13.3% |
| Dec 31, 2025 | $1.1B | +14.3% |
Revenue performance
The reported revenue decreased compared to the immediately preceding quarter, but increased compared to the same quarter one year earlier.
Quarterly comparison
For the trailing twelve months, revenue totaled an amount higher than the prior full year, supported by growth in the first three quarters of the year.
What to watch
The sequential decline after three consecutive quarters of growth may be a key indicator to monitor in upcoming periods.